Pharma deal potentially great news, but there are worries over funding
1 December 2025
Daniel Elkeles responds to the UK-US pharmaceuticals deal.
Finance
Prevention
Responding to the announcement of the UK-US pharmaceuticals deal, the chief executive of NHS Providers, Daniel Elkeles, said:
"This deal is potentially very good news for patients, for the NHS and for UK life sciences.
"It is great that NHS patients will have increased access to groundbreaking new treatments.
"The announcement also builds on the longstanding close partnership between the NHS and the pharmaceutical industry, making this the best place in the world to carry out clinical trials.
"However it is not yet clear how it will be paid for.
"There is absolutely no slack in current published NHS spending plans for this major commitment and that is a real worry for trust leaders."
Related articles
- News
NHS leaders welcome whole-government approach to improving health in Wales
19 May 2026Director of the Welsh NHS Confederation Darren Hughes responds to the First Minister's priorities for the new Welsh Government.
Prevention
Delivery and performance
Cross-sector partnerships
Community
Digital
Primary care
- News
Hard-won NHS gains at risk amid growing concerns of cuts to services
18 May 2026Sir Ciarán Devane comments on findings in new report from The NHS Alliance, highlighting the impact of growing financial pressures.
Delivery and performance
Finance
Primary care
Quality
ReportTargets and trade-offs: NHS finance and performance ambitions in 2026/27
18 May 2026Delivery and performance
Finance